Grupo Español de Rehabilitación Multimodal
13
0
2
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
7.7%
1 terminated/withdrawn out of 13 trials
75.0%
-11.5% vs industry average
8%
1 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
RICA (ERAS) Pathway Adherence and Early Discharge Feasibility After Urgent Uncomplicated Appendectomy (APENERAS)
Role: collaborator
Clinical Trial With Quetiapine Prophylaxis Postoperative Delirium in High Risk Surgical Patients
Role: collaborator
POWER AUDIT, Postoperative Outcomes Within an Enhanced Recovery After Surgery Protocol After Gastric Surgery (POWER 4 + 3)
Role: lead
Microporous Polysaccharide Hemospheres (MPH) Improving Outcome After Rectal Surgery
Role: lead
POWER AUDIT, Postoperative Outcomes Within an Enhanced Recovery After Surgery Protocol
Role: lead
Implementation of Enhanced Recovery Protocol in Spain
Role: lead
Long-term Enlarged Survival After an Enhanced Recovery Protocol (LESAS).
Role: lead
Postoperative Outcomes Within an Enhanced Recovery After Surgery Protocol in Gastric Surgery for Cancer
Role: lead
Validity of Aortic Pulse Wave Velocity in Predicting the 6- Minute Walking Test Before Major Non-cardiac Surgery
Role: lead
Postoperative Outcomes Within an Enhanced Recovery After Bariatric Surgery Protocol
Role: lead
Postoperative Outcomes Within an Enhanced Recovery After Surgery Protocol (POWER2)
Role: lead
Postopoperarive Outcomes After Colorectal Surgery in Europe (euroPOWER)
Role: lead
Postoperative Outcomes Within an Enhanced Recovery After Surgery Protocol
Role: lead
All 13 trials loaded